Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M
Source: SeekingAlpha
2025-11-13 00:54:30 ET
More on Interpace Biosciences
- Seeking Alpha’s Quant Rating on Interpace Biosciences
- Financial information for Interpace Biosciences
Read the full article on Seeking Alpha
For further details see:
Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M
Interpace Biosciences Inc.
NASDAQ: IDXG
IDXG Trading
-1.16% G/L:
$1.71 Last:
1,000 Volume:
$1.71 Open:
IDXG Latest News
January 20, 2026 09:00:00 am
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
December 03, 2025 12:12:00 pm
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners
November 12, 2025 04:01:00 pm
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
September 15, 2025 09:15:00 am
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
IDXG Stock Data
$8,015,656
3,392,512
2.13%
2
47355%
Medical Diagnostics & Screening
Healthcare
US
Parsippany
